1. Recombinant rabbit single-chain antibodies bind to the catalytic and C-terminal domains of HIV-1 integrase protein and strongly inhibit HIV-1 replication.
- Author
-
da Silva, Frederico Aires, Li, Min, Rato, Sylvie, Maia, Sara, Malhó, Rui, Warren, Kylie, Harrich, David, Craigie, Robert, Barbas, Carlos, and Goncalves, Joao
- Subjects
HIV infections ,IMMUNOGLOBULINS ,CATALYSIS ,C-terminal binding proteins ,INTEGRASES ,VIRAL replication ,CELL-mediated cytotoxicity ,PROTEIN binding - Abstract
The human immunodeficiency virus type 1 (HIV-1) integrase (IN) protein plays an important role during the early stages of the retroviral life cycle and therefore is an attractive target for therapeutic intervention. We immunized rabbits with HIV-1 IN protein and developed a combinatorial single-chain variable fragment (scFv) library against IN. Five different scFv antibodies with high binding activity and specificity for IN were identified. These scFvs recognize the catalytic and C-terminal domains of IN and block the strand-transfer process. Cells expressing anti-IN-scFvs were highly resistant to HIV-1 replication due to an inhibition of the integration process itself. These results provide proof-of-concept that rabbit anti-IN-scFv intrabodies can be designed to block the early stages of HIV-1 replication without causing cellular toxicity. Therefore, these anti-IN-scFvs may be useful agents for 'intracellular immunization'-based gene therapy strategies. Furthermore, because of their epitope binding characteristics, these scFvs can be used also as new tools to study the structure and function of HIV-1 IN protein. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF